Trillium Therapeutics (TR) News Today → Prepare for a recession unlike any other (From American Hartford Gold Group) (Ad) Free TR Stock Alerts Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSezary Syndrome Pipeline Insights 2024, Featuring Major Players 4SC, Seagen, Merck Sharp & Dohme, Innate Pharma, Trillium Therapeutics and Secura Biofinance.yahoo.com - April 15 at 1:33 PMUpstream Bio Announces Appointment of Rand Sutherland as CEO and Additions to Leadership Teamfinance.yahoo.com - April 2 at 4:07 PMRatio Announces Expansion of Manufacturing Agreement with PharmaLogic for FAP-Targeted Radiopharmaceuticalsfinance.yahoo.com - March 12 at 9:35 AMRatio Therapeutics raises $50M for tumor-targeting radiopharmaceuticalsbizjournals.com - January 17 at 10:12 AMTvardi Therapeutics Announces First Patients Dosed in its Phase 2 Liver Cancer Trial Using TTI-101, a Novel STAT3 Inhibitorfinance.yahoo.com - June 22 at 7:10 PMPD-1 Non-Small Cell Lung Cancer Clinical Trials Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space | DelveInsightbenzinga.com - June 20 at 3:57 PMRatio Therapeutics Announces Opening of New Research and Development Facilityfinance.yahoo.com - May 9 at 8:17 AMTrillium Engineering Announces Its Latest Innovation in Cameras Utilizing AI Technology - HD80-AIMfinance.yahoo.com - April 25 at 9:23 PMWho's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Personmsn.com - March 10 at 6:25 PMViridian Therapeutics, Inc: Viridian Appoints Scott Myers as President and Chief Executive Officerfinanznachrichten.de - February 6 at 7:52 AMTaylor Trillium building into Division 4 state power, behind coach Terrell Georgedetroitnews.com - January 28 at 1:45 AMLeiomyosarcoma Drug Pipeline Research Report 2022: Comprehensive Insights on 18+ Companies and 18+ Pipeline Drugsbenzinga.com - December 19 at 8:07 AMRatio Therapeutics Appoints Reed Malleck as Chief Financial Officerfinance.yahoo.com - December 6 at 12:57 PMPfizer: Q3 Earnings Review - Planning For Life After COVIDseekingalpha.com - November 3 at 5:45 PMCash-rich Pfizer snaps up Global Blood Therapeutics for $5.4 billionmsn.com - August 8 at 5:43 PMPfizer: Management's M&A Activity Is Winning Me Overseekingalpha.com - May 22 at 4:23 AMThiogenesis Therapeutics, Corp.: Thiogenesis Announces Positive Results from Phase 1 Dose-Escalation Study of its Lead Compound TTI-0102finanznachrichten.de - May 18 at 11:34 AMThiogenesis Announces Positive Results from Phase 1 Dose-Escalation Study of its Lead Compound TTI-0102stockhouse.com - May 18 at 11:34 AM3 Dirt-Cheap Stocks You Can Buy Right Nowmsn.com - May 14 at 7:50 AMPfizer Buys Biohaven for $11.6Bbaystreet.ca - May 10 at 10:43 AMNeonMind to Open its Inaugural Specialty Mental Health Clinic in Mississauga, Ontariomorningstar.com - February 17 at 2:13 PM$51,300 OTF Grant helped breast cancer patients in Ontario access educational resources during the pandemicyahoo.com - January 25 at 8:01 PMTCR² Therapeutics Announces Experienced Biotech Executive Rosemary Harrison as Chief Business and Strategy Officerfinance.yahoo.com - January 12 at 9:40 AMSensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent Directorapnews.com - December 20 at 1:45 AMPfizer's $2.3B Trillium Deal Closes Without FTC Challengelaw360.com - November 17 at 7:59 PMWhy Pfizer Rose While the Market Sank on Wednesdaynasdaq.com - November 17 at 7:59 PMQVT Financial LP Buys S&P 500 ETF TRUST ETF, Trillium Therapeutics Inc, Nelnet Inc, Sells ...gurufocus.com - November 17 at 1:37 PMPfizer Completes Acquisition of Trillium Therapeuticsfinance.yahoo.com - November 17 at 9:58 AMPfizer Agrees $2.26 Billion Takeover of Cancer Specialists Trillium Therapeuticsmsn.com - August 23 at 3:22 PMPfizer acquires Trillium Therapeutics at a 200% premiumbizjournals.com - August 23 at 3:22 PMBRIEF-Pfizer To Acquire Trillium Therapeutics Inc.msn.com - August 23 at 9:32 AMPremarket Movers Monday - Pfizer, Trillium, Uber and General Motorsmsn.com - August 23 at 9:32 AMPromising Treatment for Cutaneous T-cell Lymphoma Enters Clinical Trialsca.finance.yahoo.com - August 3 at 8:08 PMThis Biotech Stock Is Too Cheap to Ignorenasdaq.com - July 29 at 11:48 AMStocks Flat to Begin Weekbaystreet.ca - July 26 at 1:47 PMStocks Stable by Noonbaystreet.ca - July 26 at 1:47 PM Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TR and its competitors with MarketBeat's FREE daily newsletter. Email Address Prepare for a recession unlike any other (Ad)These 42 powerful nations just launched the first-ever “Anti-Dollar Alliance”… And together, they plan to KILL the greenback and DETHRONE America once and for all. Leading the charge are the usual suspects: Russia, China, Iran, oil-soaked Saudi Arabia, and even our neighbor, Mexico. And because this alliance holds close to 70% of all US Dollars… Ditching their holdings could flood America with a tsunami of US Dollars… Triggering hyper-inflation and a Wall Street nosedive so deep, it VAPORIZES trillions in hard-earned retirement savings. GET THE FREE GUIDE TR Media Mentions By Week TR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TR News Sentiment▼0.000.52▲Average News Sentiment TR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TR Articles This Week▼00▲TR Articles Average Week Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:TR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trillium Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
